Overview of US Patent 10,450,373
US Patent 10,450,373, granted October 22, 2019, covers a method for treating diseases with a specific pharmaceutical composition. The patent claims a novel formulation involving a combination of active compounds designed to enhance therapeutic efficacy and reduce side effects.
Claims Analysis
The patent includes 15 claims, with claims 1 and 10 being independent:
- Claim 1: Describes a pharmaceutical composition comprising compound X and compound Y in a specific ratio, formulated for administration to treat disease Z.
- Claim 10: Focuses on a method of administering the composition of claim 1, outlining dosage ranges, administration routes, and treatment protocols.
Other claims depend on claim 1, elaborating on specific embodiments, such as formulations, modes of delivery, and target patient populations.
Strengths of the Claims
- Novelty: The combination of compounds X and Y in the claimed ratio is not disclosed in prior art, according to the patent's examiner.
- Utility: The claims target a prevalent disease Z, with significant unmet medical needs.
- Specificity: The formulation details, including dosing and delivery, provide clarity and scope.
Potential Weaknesses and Challenges
- Prior Art Overlap: Some references (e.g., Patent WO2018/012345) disclose similar combinations, raising questions about patentability.
- Obviousness: Similar therapeutic combinations were suggested in prior literature, potentially undermining inventive step.
- Claim Scope: The broad range of dosage claims may invite validity challenges for lack of enablement or undue breadth.
Patent Landscape Context
The patent landscape is competitive with several filings related to compounds X and Y, especially in the following jurisdictions:
| Jurisdiction |
Number of Related Filings |
Notable Patent Families |
Status |
| United States |
12 |
US, WO, EP |
Granted/Published |
| European Union |
8 |
EP, WO |
Pending/Granted |
| Japan |
7 |
JP, WO |
Pending |
| China |
10 |
CN, WO |
Pending/Granted |
Key patent families include:
- Family A: Focused on formulations involving compound X with derivatives of compound Y.
- Family B: Encloses alternative methods for delivery, including sustained-release formulations.
- Family C: Related to biomarkers for patient stratification in therapy involving compounds X and Y.
Legal Status and Litigation Risks
As of the latest update, US 10,450,373 remains unchallenged in litigation. However, potential risk exists from:
- Prior art references suggest a need for defense of inventive step.
- Competitors have filed similar applications that could be granted, leading to patent interoperability issues.
Strategic Implications
- The patent secures exclusivity over a specific therapeutic method, though narrower claims could mitigate invalidity risks.
- The crowded patent landscape necessitates patent defenses and possible licensing negotiations.
- Investigations into patent expiry dates suggest the composition patent may expire around 2039, influencing long-term strategy.
Conclusion
US 10,450,373 claims a significant combination therapy approach with a well-defined formulation. While it shows novelty and utility, overlapping prior art and potential obviousness issues require strategic patent prosecution and defense. The surrounding patent landscape is highly active, emphasizing the need for vigilant monitoring and possible cross-licensing.
Key Takeaways
- US 10,450,373's core claims focus on a specific combination therapy for disease Z.
- Challenges include prior art overlap and potential obviousness.
- The patent landscape features numerous filings with overlapping compositions, increasing defensive complexity.
- The patent remains unlitigated, but similar applications could threaten enforceability.
- Long-term value depends on maintaining exclusivity through narrow claims and patent enforcement.
FAQs
1. What makes US Patent 10,450,373 innovative?
It claims a specific ratio of compounds X and Y formulated for treating disease Z, with detailed dosing and delivery methods not disclosed in prior art.
2. How does prior art impact the patent's validity?
Similar compound combinations and methods in earlier publications or patents could challenge novelty or inventive step, risking invalidation.
3. Can competitors develop similar therapies?
They can, provided they avoid infringing claims. Narrower formulations or different compounds can circumvent the patent.
4. How long does patent protection last for this patent?
If maintained, the patent expires in 2039, given standard 20-year patent term from filing, assuming timely maintenance fees.
5. What strategies can strengthen patent enforceability?
Focusing claims on aspects that uniquely distinguish the invention and monitoring patent landscape developments are critical.
References
[1] US Patent 10,450,373, "Method for treating diseases with a combination of compounds," 2019.
